Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2009 Filed Jul 1, 2009 20:24 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 124 | $15.00 | $1,860.00 |
DisclosureSEC source: 0000078003-09-000139 · mac2082.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,799 Underlying: Common Stock · 124 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 20:24 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 306 | $15.00 | $4,590.00 |
DisclosureSEC source: 0000078003-09-000140 · rea2083.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,920 Underlying: Common Stock · 306 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 20:24 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 77 | $15.00 | $1,155.00 |
DisclosureSEC source: 0000078003-09-000141 · ric2085.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,276 Underlying: Common Stock · 77 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 20:24 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 163 | $15.00 | $2,445.00 |
DisclosureSEC source: 0000078003-09-000142 · rin2086.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,159 Underlying: Common Stock · 163 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2009 Filed Jul 1, 2009 20:25 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 93 | $15.00 | $1,395.00 |
DisclosureSEC source: 0000078003-09-000143 · sus2088.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,395 Underlying: Common Stock · 93 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 26, 2009 Filed Jun 30, 2009 20:55 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 3,027 | $15.19 | $45,980.13 |
DisclosureSEC source: 0000078003-09-000133 · mea2076.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,460 Underlying: Common Stock · 3,027 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2009 Filed Jun 30, 2009 20:55 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 1,959 | $15.19 | $29,757.21 |
DisclosureSEC source: 0000078003-09-000132 · kil2074.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,876 Underlying: Common Stock · 1,959 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2009 Filed Jun 30, 2009 20:55 UTC |
SANGER STEPHEN WDirector
|
GrantPhantom Stock Units · Derivative | 1,844 | $15.19 | $28,010.36 |
DisclosureSEC source: 0000078003-09-000134 · san2077.xml · derivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,852 Underlying: Common Stock · 1,844 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 26, 2009 Filed Jun 30, 2009 20:55 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 2,142 | $15.19 | $32,536.98 |
DisclosureSEC source: 0000078003-09-000135 · ste2075.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,943 Underlying: Common Stock · 2,142 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 80 | $14.13 | $1,130.40 |
DisclosureSEC source: 0000078003-09-000124 · can2063.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,510 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 142 | $14.13 | $2,006.46 |
DisclosureSEC source: 0000078003-09-000125 · dam2064.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,986 Underlying: Common Stock · 142 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 226 | $14.13 | $3,193.38 |
DisclosureSEC source: 0000078003-09-000126 · kin2065.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,544 Underlying: Common Stock · 226 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 136 | $14.13 | $1,921.68 |
DisclosureSEC source: 0000078003-09-000127 · mac2066.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,675 Underlying: Common Stock · 136 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 389 | $14.13 | $5,496.57 |
DisclosureSEC source: 0000078003-09-000128 · rea2067.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,614 Underlying: Common Stock · 389 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 108 | $14.13 | $1,526.04 |
DisclosureSEC source: 0000078003-09-000129 · ric2070.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,199 Underlying: Common Stock · 108 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 100 | $14.13 | $1,413.00 |
DisclosureSEC source: 0000078003-09-000131 · sus2069.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302 Underlying: Common Stock · 100 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2009 Filed Jun 16, 2009 19:55 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 177 | $14.13 | $2,501.01 |
DisclosureSEC source: 0000078003-09-000130 · rin2068.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,996 Underlying: Common Stock · 177 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 12, 2009 Filed Jun 12, 2009 16:41 UTC |
RICCIARDI NATALE SSenior Vice President
|
SaleCommon Stock | 300 | $14.76 | $4,428.00 |
DisclosureSEC source: 0000078003-09-000123 · ric2060.xml · nonDerivative · entry 3 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,431 Read SEC document |
| June 12, 2009 Filed Jun 12, 2009 16:41 UTC |
RICCIARDI NATALE SSenior Vice President
|
SaleCommon Stock | 14,400 | $14.75 | $212,400.00 |
DisclosureSEC source: 0000078003-09-000123 · ric2060.xml · nonDerivative · entry 2 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,731 Read SEC document |
| June 12, 2009 Filed Jun 12, 2009 16:41 UTC |
RICCIARDI NATALE SSenior Vice President
|
SaleCommon Stock | 300 | $14.74 | $4,422.00 |
DisclosureSEC source: 0000078003-09-000123 · ric2060.xml · nonDerivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,131 Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 73 | $15.19 | $1,108.87 |
DisclosureSEC source: 0000078003-09-000113 · can2048.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,430 Underlying: Common Stock · 73 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 131 | $15.19 | $1,989.89 |
DisclosureSEC source: 0000078003-09-000114 · dam2049.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,844 Underlying: Common Stock · 131 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 193 | $15.19 | $2,931.67 |
DisclosureSEC source: 0000078003-09-000115 · kin2058.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,318 Underlying: Common Stock · 193 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 125 | $15.19 | $1,898.75 |
DisclosureSEC source: 0000078003-09-000116 · mac2052.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,539 Underlying: Common Stock · 125 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 333 | $15.19 | $5,058.27 |
DisclosureSEC source: 0000078003-09-000117 · rea2053.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,225 Underlying: Common Stock · 333 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 88 | $15.19 | $1,336.72 |
DisclosureSEC source: 0000078003-09-000118 · ric2054.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,091 Underlying: Common Stock · 88 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 163 | $15.19 | $2,475.97 |
DisclosureSEC source: 0000078003-09-000119 · rin2055.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,819 Underlying: Common Stock · 163 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 13:58 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 92 | $15.19 | $1,397.48 |
DisclosureSEC source: 0000078003-09-000120 · sus2056.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,202 Underlying: Common Stock · 92 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 29, 2009 Filed Jun 2, 2009 18:43 UTC |
Lewis-Hall Freda CSenior Vice President
|
GrantCommon Stock | 65,833 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000121 · lew2059.xml · nonDerivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,833 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 109 | $15.01 | $1,636.09 |
DisclosureSEC source: 0000078003-09-000103 · can2038.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,357 Underlying: Common Stock · 109 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 200 | $15.01 | $3,002.00 |
DisclosureSEC source: 0000078003-09-000104 · dam2039.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,713 Underlying: Common Stock · 200 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 640 | $15.01 | $9,606.40 |
DisclosureSEC source: 0000078003-09-000105 · kin2040.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,125 Underlying: Common Stock · 640 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 180 | $15.01 | $2,701.80 |
DisclosureSEC source: 0000078003-09-000106 · mac2041.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,414 Underlying: Common Stock · 180 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 950 | $15.01 | $14,259.50 |
DisclosureSEC source: 0000078003-09-000107 · rea2042.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,892 Underlying: Common Stock · 950 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 363 | $15.01 | $5,448.63 |
DisclosureSEC source: 0000078003-09-000108 · ric2043.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,003 Underlying: Common Stock · 363 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 125 | $15.01 | $1,876.25 |
DisclosureSEC source: 0000078003-09-000110 · sus2045.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,110 Underlying: Common Stock · 125 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2009 Filed May 18, 2009 20:53 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 211 | $15.01 | $3,167.11 |
DisclosureSEC source: 0000078003-09-000109 · rin2044.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,656 Underlying: Common Stock · 211 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 13, 2009 Filed May 15, 2009 16:15 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GiftCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000102 · kin2037.xml · nonDerivative · entry 4 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for Son Disclosed balance after: 2,350 F1 · kind: These transactions constitute gifts by the reporting person to trusts for the benefit of his children. F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by such trusts. Read SEC document |
| May 13, 2009 Filed May 15, 2009 16:15 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GiftCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000102 · kin2037.xml · nonDerivative · entry 3 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust for Daughter Disclosed balance after: 2,350 F1 · kind: These transactions constitute gifts by the reporting person to trusts for the benefit of his children. F2 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by such trusts. Read SEC document |
| May 13, 2009 Filed May 15, 2009 16:15 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GiftCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000102 · kin2037.xml · nonDerivative · entry 2 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,098 F1 · kind: These transactions constitute gifts by the reporting person to trusts for the benefit of his children. Read SEC document |
| May 13, 2009 Filed May 15, 2009 16:15 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GiftCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000102 · kin2037.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,498 Read SEC document |
| May 11, 2009 Filed May 11, 2009 21:13 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
SaleCommon Stock | 21,411 | $14.24 | $304,892.64 |
DisclosureSEC source: 0000078003-09-000101 · can2036.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,773 Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:00 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 82 | $13.36 | $1,095.52 |
DisclosureSEC source: 0000078003-09-000092 · can2027.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 82 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:00 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 146 | $13.36 | $1,950.56 |
DisclosureSEC source: 0000078003-09-000093 · dam2028.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,513 Underlying: Common Stock · 146 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:00 UTC |
GOODMAN COREY SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 102 | $13.36 | $1,362.72 |
DisclosureSEC source: 0000078003-09-000094 · goo2029.xml · derivative · entry 1 GOODMAN COREY S · CIK 0001278411 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350 Underlying: Common Stock · 102 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:00 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 209 | $13.36 | $2,792.24 |
DisclosureSEC source: 0000078003-09-000095 · kin2030.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,485 Underlying: Common Stock · 209 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:00 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 141 | $13.36 | $1,883.76 |
DisclosureSEC source: 0000078003-09-000096 · mac2031.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,234 Underlying: Common Stock · 141 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:00 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 390 | $13.36 | $5,210.40 |
DisclosureSEC source: 0000078003-09-000097 · rea2032.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,942 Underlying: Common Stock · 390 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:01 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 103 | $13.36 | $1,376.08 |
DisclosureSEC source: 0000078003-09-000098 · ric2033.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,640 Underlying: Common Stock · 103 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2009 Filed May 1, 2009 18:01 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 185 | $13.36 | $2,471.60 |
DisclosureSEC source: 0000078003-09-000099 · rin2034.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,445 Underlying: Common Stock · 185 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.